Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Mather, California Clinical Trials

A listing of Mather, California clinical trials actively recruiting patient volunteers.

RESULTS

Found (6) clinical trials

Assessing Fluid Status of Peritoneal Dialysis Patients With Assistance of Lung Ultrasound

Study Design: Cross-sectional study, inviting PD patients at 10 Northern CA home dialysis units to participate. One-time ultrasound done during monthly nurse visit between December 2019 and March 2020. All patients present for their monthly visit at participating home dialysis units on days in which ultrasound available will be eligible, ...

Phase N/A

7.95 miles

Learn More »

Radicava (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)

Treatment will be prescribed by HCPs in accordance with their clinical judgement and the prescribing information for Edaravone. The decision to prescribe Edaravone to the participants should be made separately from the decision to enroll then in the study. There will be no randomized assignments to treatment and no restrictions ...

Phase N/A

9.73 miles

Learn More »

MitraClip EXPAND G4 Study

This is a post-market, multi-center, single-arm, prospective study to assess the safety and performance of the next generation MitraClip G4 System. The current protocol describes the design of this post-market study. Up to 100 post-market, consecutive, consented, patients treated with a MitraClip G4 device will be included for analysis into ...

Phase N/A

9.73 miles

Learn More »

Effects of Brain Stimulation on Cognition Oscillations and GABA Levels in Schizophrenia

The purpose of this study is to use a non-invasive brain stimulation technique, transcranial direct current stimulation (tDCS), to test a set of hypotheses about the role of the prefrontal cortex in behavioral and neural correlates of cognition in schizophrenia. Behavioral, electrophysiological (EEG) and neuroimaging measures will be used to ...

Phase N/A

9.73 miles

Learn More »

Testing the Combination of New Anti-cancer Drug Nedisertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

PRIMARY OBJECTIVES: I. To determine the safety and tolerability and recommended phase 2 dose (RP2D) of nedisertib (M3814) in combination with hypofractionated radiation and avelumab in patients with advanced/metastatic solid tumors. (Phase I) II. To determine the efficacy of the combination of hypofractionated radiation, M3814, and avelumab as compared to ...

Phase

9.73 miles

Learn More »